Pharmena S.A. (PHR) — Capital Reinvestment Ratio
Pharmena S.A. (PHR) has a Capital Reinvestment Ratio of 0.00x as of June 2023, meaning it reinvests 0% of its operating cash flow (zł44.83 Million) in capital expenditures (zł131.00K). See how leveraged is Pharmena S.A.'s balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Pharmena S.A. Capital Reinvestment Ratio (2011–2023)
This chart tracks Pharmena S.A.'s Capital Reinvestment Ratio across 5 annual periods. Check total reinvestment intensity of Pharmena S.A. to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Pharmena S.A. (2011–2023)
Year-by-year Capital Reinvestment Ratio for Pharmena S.A. from 2011 to 2023. For live market cap and broader valuation context, see PHR market cap overview.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.01x | zł33.03 Million | zł314.00K | ▼ -92.3% |
| 2022 | 0.12x | zł1.82 Million | zł226.00K | ▲ +0.6% |
| 2018 | 0.12x | zł3.61 Million | zł446.00K | ▼ -61.2% |
| 2017 | 0.32x | zł619.00K | zł197.00K | ▲ +208.1% |
| 2011 | 0.10x | zł666.91K | zł68.89K | — |